adrenergic beta receptor non-selective antagonist drug pathway sotalol drug pathway 2015-08-20T11:09:58Z PW:0001828 The pharmacokinetics and pharmacodynamics pathway of sotalol - a non-selective adrenergic beta receptor blocker. It binds and inhibits the beta 1 and beta 2 receptors and is used for the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug. pathway vpetri